Publication: Synthesis of bis, tris and tetra(dihydrocaffeoyl)polyamine conjugates as antibacterial agents against VRSA
| dc.contributor.author | Yingyongnarongkul B.-E. | |
| dc.contributor.author | Apiratikul N. | |
| dc.contributor.author | Aroonrerk N. | |
| dc.contributor.author | Suksamrarn A. | |
| dc.date.accessioned | 2021-04-05T04:31:59Z | |
| dc.date.available | 2021-04-05T04:31:59Z | |
| dc.date.issued | 2008 | |
| dc.date.issuedBE | 2551 | |
| dc.description.abstract | Bis, tris and tetra(dihydrocaffeoyl)polyamine conjugates were synthesized using solid phase synthesis technique. These compounds were screened for antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) (11 strains) and vancomycin-resistant S. aureus (VRSA) (4 strains). Bis, tris and tetra(dihydrocaffeoyl)polyamine analogues showed antibacterial activity against VRSA which were better than the reference drugs, vancomycin. Tetra(dihydrocaffeoyl) polyamine conjugate exhibited the highest activity. These compounds showed no cytotoxicity against vero cells. © 2008 The Pharmaceutical Society of Korea. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Archives of Pharmacal Research. Vol 31, No.6 (2008), p.698-704 | |
| dc.identifier.doi | 10.1007/s12272-001-1215-4 | |
| dc.identifier.issn | 2536269 | |
| dc.identifier.other | 2-s2.0-45749097459 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/4010 | |
| dc.rights.holder | Scopus | |
| dc.subject.other | 3,4-dihydroxyphenylpropionic acid | |
| dc.subject.other | Antiinfective agent | |
| dc.subject.other | Caffeic acid derivative | |
| dc.subject.other | Dihydrocaffeic acid | |
| dc.subject.other | Drug derivative | |
| dc.subject.other | Spermidine | |
| dc.subject.other | Animal | |
| dc.subject.other | Antibiotic resistance | |
| dc.subject.other | Article | |
| dc.subject.other | Cell survival | |
| dc.subject.other | Cercopithecus | |
| dc.subject.other | Chemical structure | |
| dc.subject.other | Dose response | |
| dc.subject.other | Drug effect | |
| dc.subject.other | Growth, development and aging | |
| dc.subject.other | IC 50 | |
| dc.subject.other | Microbiological examination | |
| dc.subject.other | Penicillin resistance | |
| dc.subject.other | Staphylococcus aureus | |
| dc.subject.other | Synthesis | |
| dc.subject.other | Vero cell | |
| dc.subject.other | Animals | |
| dc.subject.other | Anti-Bacterial Agents | |
| dc.subject.other | Caffeic Acids | |
| dc.subject.other | Cell Survival | |
| dc.subject.other | Cercopithecus aethiops | |
| dc.subject.other | Dose-Response Relationship, Drug | |
| dc.subject.other | Inhibitory Concentration 50 | |
| dc.subject.other | Methicillin Resistance | |
| dc.subject.other | Microbial Sensitivity Tests | |
| dc.subject.other | Molecular Structure | |
| dc.subject.other | Spermidine | |
| dc.subject.other | Staphylococcus aureus | |
| dc.subject.other | Vancomycin Resistance | |
| dc.subject.other | Vero Cells | |
| dc.title | Synthesis of bis, tris and tetra(dihydrocaffeoyl)polyamine conjugates as antibacterial agents against VRSA | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-45749097459&doi=10.1007%2fs12272-001-1215-4&partnerID=40&md5=9d9df22ae5f6bc2755552008dc25c54d |
